脐血干细胞移植成功治疗早发IPEX综合征1例报告并文献复习

doi:10.12372/jcp.2023.22e0712

摘要/Abstract

摘要：

X连锁多内分泌腺病肠病伴免疫失调综合征(IPEX ) 是一种由FOXP3基因变异引起的原发性免疫缺陷病，典型表现包括严重肠病、1型糖尿病和湿疹三联征。患儿，男，以糖尿病、顽固性腹泻、湿疹、反复感染起病，经遗传学检测确诊为FOXP3基因变异引起的IPEX综合征，最终经脐血干细胞移植治疗，患儿自身免疫症状得到改善。对早发糖尿病、顽固性腹泻及湿疹婴幼儿，应考虑IPEX综合征可能并进行遗传学检测，早期造血干细胞移植可阻止大多数患儿的疾病进展和并发症的发生，提高患儿生存率。

关键词: X连锁多内分泌腺病肠病伴免疫失调综合征, 糖尿病, 腹泻, 湿疹, 造血干细胞移植

Abstract:

The X-linked polyendocrine adenopathy enteropathy with immune disorder syndrome (IPEX ) is a primary immunodeficiency disease caused by a variant of the FOXP3 gene, typically presenting with a triad of severe enteropathy, type 1 diabetes mellitus and eczema. The child, a male, started with diabetes, intractable diarrhea, eczema, and recurrent infections, and was diagnosed with IPEX syndrome caused by FOXP3 gene variant by genetic testing, and was eventually treated with umbilical cord blood stem cell transplantation, which improved the child's autoimmune symptoms. In infants with early onset diabetes, intractable diarrhea and eczema, IPEX syndrome should be considered, and genetic testing should be performed. Early hematopoietic stem cell transplantation can prevent disease progression and complications in most children and improve their survival rate.

Key words: immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, diabetes, diarrh ea, eczema, hematopoietic stem cell transplantation

许普, 钱晓文, 翟晓文, 王来栓. 脐血干细胞移植成功治疗早发IPEX综合征1例报告并文献复习[J]. 临床儿科杂志, 2023, 41(2): 140-145.

XU Pu, QIAN Xiaowen, ZHAI Xiaowen, WANG Laishuan. Successful treatment of a case of premature IPEX syndrome with umbilical cord blood stem cell transplantation and literature review[J]. Journal of Clinical Pediatrics, 2023, 41(2): 140-145.

图/表 1

参考文献 40

[1]	d'Hennezel E, Bin Dhuban K, Torgerson T, et al. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome[J]. J Med Genet, 2012, 49(5): 291-302. doi: 10.1136/jmedgenet-2012-100759 pmid: 22581967
[2]	Park JH, Lee KH, Jeon B, et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: a systematic review[J]. Autoimmun Rev, 2020, 19(6): 102526. doi: 10.1016/j.autrev.2020.102526
[3]	朱琼, 袁珂, 王春林, 等. FOXP3基因突变致X连锁多内分泌腺病肠病伴免疫失调综合征二例[J]. 中华医学遗传学杂志, 2018, 35(3): 389-392.
[4]	王筠, 周莉, 孙梦娇, 等. IPEX综合征1例报告并文献复习[J]. 临床儿科杂志, 2021, 39(10): 775-778.
[5]	Hossain E, 田亚, 陈源, 等. IPEX综合征并发肠源性脓毒症1例并文献复习[J]. 临床荟萃, 2021, 36(5): 453-457.
[6]	罗晓波. IPEX综合征及XLP-1临床与分子特点分析[D]. 重庆: 重庆医科大学, 2013.
[7]	王欢, 周方, 王跃生, 等. X-连锁多内分泌腺病肠病伴免疫失调综合征1例并文献分析[J]. 长治医学院学报, 2021, 35(5): 378-380.
[8]	董文芳, 曹清, 王剑, 等. X连锁多内分泌腺病肠病伴免疫失调综合征二例并文献复习[J]. 中国小儿急救医学, 2018, 25(10): 753-756.
[9]	安云飞, 赵晓东, 许峰, 等. X连锁多内分泌腺病肠病伴免疫失调综合征一例基因及蛋白表达研究[J]. 中华儿科杂志, 2009, 47(11): 824-828.
[10]	谭力文. 儿童X连锁多内分泌腺病肠病伴免疫失调综合征相关膜性肾病2例及文献复习[D]. 重庆: 重庆医科大学, 2021.
[11]	何庭艳, 夏宇, 梁芳芳, 等. 先天性鱼鳞病样皮肤病变IPEX 1例报告并文献复习[J]. 临床儿科杂志, 2017, 35(8): 620-624.
[12]	周方, 王瑞锋, 于志丹, 等. 一例晚发X-连锁多内分泌腺病肠病伴免疫失调综合征患儿的临床及遗传学研究[J]. 中华医学遗传学杂志, 2021, 38(3): 255-259.
[13]	鲍文婷, 李在玲, 李军, 等. 以极早发型炎症性肠病样改变为主要特征的X连锁多内分泌腺病肠病伴免疫失调综合征一例[J]. 中华儿科杂志, 2019, 57(7): 559-561.
[14]	刘丙菊, 管国涛, 赵平, 等. 以自身免疫性溶血性贫血起病的IPEX 1例[J]. 中国小儿血液与肿瘤杂志, 2020, 25(2): 104-106.
[15]	王依柔, 张倩文, 丁宇, 等. 造血干细胞移植治疗以新生儿糖尿病起病的IPEX综合征:临床随访及文献复习[J]. 中华内分泌代谢杂志, 2021, 37(4): 288-292.
[16]	Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy[J]. J Pediatr, 1982, 100(5): 731-737.
[17]	Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3[J]. Nat genet, 2001, 27(1): 20-21. doi: 10.1038/83713 pmid: 11137993
[18]	Ziegler SF. FOXP3: of mice and men[J]. Ann Rev Immunol, 2006, 24: 209-226. doi: 10.1146/annurev.immunol.24.021605.090547
[19]	Torgerson TR, Linane A, Moes N, et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene[J]. Gastroenterology, 2007, 132(5): 1705-1717. pmid: 17484868
[20]	Bacchetta R, Barzaghi F, Roncarolo MG. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation[J]. Anna N Y Acad Sci, 2018, 1417(1): 5-22.
[21]	Barzaghi F, Amaya Hernandez LC, Neven B, et al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study[J]. J Allergy Clin Immunol, 2018, 141(3): 1036-1049. doi: S0091-6749(17)31893-6 pmid: 29241729
[22]	Duclaux-Loras R, Charbit-Henrion F, Neven B, et al. Clinical heterogeneity of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a French multicenter retrospective study[J]. Clin Transl Gastroenterol, 2018, 9(10): 201.
[23]	Hwang JL, Park SY, Ye H, et al. FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome[J]. Pediatr Diabetes, 2018, 19(3): 388-392. doi: 10.1111/pedi.12612
[24]	Ge T, Wang Y, Che Y, et al. Atypical late-onset immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome with intractable diarrhea: a case report[J]. Front Pediatr, 2017, 5: 267. doi: 10.3389/fped.2017.00267 pmid: 29312905
[25]	Luo Y, Chen J, Fang Y, et al. A case of metaplastic atrophic gastritis in immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome[J]. BMC Pediatr, 2018, 18(1): 191. doi: 10.1186/s12887-018-1169-9 pmid: 29907148
[26]	Zama D, Cocchi I, Masetti R, et al. Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea[J]. Ital J Pediatr, 2014, 40: 68. doi: 10.1186/s13052-014-0068-4 pmid: 25326164
[27]	De Benedetti F, Insalaco A, Diamanti A, et al. Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome[J]. Clin Gastroenterol Hepatol, 2006, 4(5): 653-659. doi: 10.1016/j.cgh.2005.12.014
[28]	Lampasona V, Passerini L, Barzaghi F, et al. Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome[J]. PLoS One, 2013, 8(11): e78664. doi: 10.1371/journal.pone.0078664
[29]	Gambineri E, Perroni L, Passerini L, et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity[J]. J Allergy Clin Immunol, 2008, 122(6): 1105-1112. doi: 10.1016/j.jaci.2008.09.027 pmid: 18951619
[30]	Passerini L, Barzaghi F, Curto R, et al. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients[J]. J Allergy Clin Immunol, 2020, 145(4): 1262-1271. doi: S0091-6749(19)32592-8 pmid: 31874182
[31]	Yamauchi T, Takasawa K, Kamiya T, et al. Hematopoietic stem cell transplantation recovers insulin deficiency in type 1 diabetes mellitus associated with IPEX syndrome[J]. Pediatr Diabetes, 2019, 20(7): 1035-1040. doi: 10.1111/pedi.12895 pmid: 31322807
[32]	Nademi Z, Slatter M, Gambineri E, et al. Single centre experience of haematopoietic SCT for patients with immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome[J]. Bone Marrow Transplant, 2014, 49(2): 310-312. doi: 10.1038/bmt.2013.181
[33]	Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome[J]. J Med Genet, 2002, 39(8): 537-545. doi: 10.1136/jmg.39.8.537 pmid: 12161590
[34]	Kucuk ZY, Bleesing JJ, Marsh R, et al. A challenging undertaking: stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome[J]. J Allergy Clin Immunol, 2016, 137(3): 953-955. doi: 10.1016/j.jaci.2015.09.030 pmid: 26559324
[35]	Burroughs LM, Nemecek ER, Torgerson TR, et al. Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial[J]. Biol Blood Marrow Transplant, 2014, 20(12): 1996-2003. doi: 10.1016/j.bbmt.2014.08.020
[36]	Rao A, Kamani N, Filipovich A, et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning[J]. Blood, 2007, 109(1): 383-385. doi: 10.1182/blood-2006-05-025072 pmid: 16990602
[37]	Burroughs LM, Torgerson TR, Storb R, et al. Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome[J]. J Allergy Clin Immunol, 2010, 126(5): 1000-1005. doi: 10.1016/j.jaci.2010.05.021 pmid: 20643476
[38]	Passerini L, Rossi Mel E, Sartirana C, et al. CD4⁺ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer[J]. Sci Transl Med, 2013, 5(215): 215ra174.
[39]	Passerini L, Santoni de Sio FR, Porteus MH, et al. Gene/cell therapy approaches for immune dysregulation polyendocrinopathy enteropathy X-linked syndrome[J]. Curr Gene Ther, 2014, 14(6): 422-428. doi: 10.2174/1566523214666141001123828 pmid: 25274247
[40]	Bacchetta R, Passerini L, Gambineri E, et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations[J]. J Clin Invest, 2006, 116(6): 1713-1722. doi: 10.1172/JCI25112 pmid: 16741580